A comparison of tetanus antibody levels between patients with high body mass indices and normal patients

Aim: It has recently been thought that obesity may cause metabolic diseases as well as being linked to immune system dysfunction. The purpose of this study was to compare tetanus antibody levels between patients with high body mass indices and healthy-weight individuals and to examine the effect of obesity on tetanus antibody levels in adults. Materials and Methods: This cross-sectional research was performed at Duzce University,Faculty of Medicine from December 2018 to February 2019. The study group was composed of obese patients who had undergone tetanus immunization within the previous 10 years. The control group consisted of healthy-weight individuals who had also been immunized in the previous 10 years. An enzyme-linked immunosorbent assay kit (Euroimmun, Germany) was used to detect antibodies to tetanus toxoid. Results: Sixty-seven individuals with obesity and 21 controls participated in this study. Anti-tetanus IgG antibodies were at protective levels in both groups, although the mean antibody level in the patients with obesity was significantly lower compared to the control group (0.788±0.602 vs 1.112±0.398, p=0.022). Anti-tetanus IgG antibodies were significantly negatively correlated with BMI (r=- 0.269, p=0.016). Conclusion: The detection of low levels of tetanus antibody titers in patients with high BMI in this study compared to the control group suggests that greater attention is required in this population.

PDF

___

1. Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. AMA Arch Intern Med 2002;162:2074-9.
2. Painter SD, Ovsyannikova IG, Polanda GA. The weight of obesity on the human immune response to vaccination. Vaccine 2015;33:4422-9.
3. National Institutes of Health. Clinical guidelines on the identification evaluation and treatment of overweight obesity in adults--The evidence report. Obes Res 1998;6:51-209.
4. Bailey KV, Ferro-Luzzi A. Use of body mass index of adults in assessing individual and community nutritional status. Bull World Health Organ 1995;73:673-80.
5. Louie JK, Acosta M, Winter K, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. J Am Med Assoc 2009;302:1896-902.
6. https://www.cdc.gov/nchs/data/databriefs/db360-h. pdf (Accessed date 13 June 2020)
7. Vermeulen A. The epidemic of obesity: Obesity and health of the aging male. The Aging Male 2005;8:39- 41.
8. Tagliabue C, Principi N, Giavoli C, et al. Obesity: impact of infections and response to vaccines. Eur J ClinMicrobiol Infect Dis 2016;35:325-31.
9. Andre FE, Booy R, Bock HL, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ 2008;86:140-6.
10. Weber DJ, Rutala WA, Samsa GP, et al. Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. Jama 1985;254:3187-9.
11. Grant RW, Dixit VD. Adipose tissue as an immunological organ. Obesity (Silver Spring) 2015;23:512-8.
12. Eliakim A, Schwindt C, Zaldivar F, et al. Reduced tetanus antibody titers in overweight children. Autoimmunity 2006;39:137-41.
13. Banga N, Guss P, Banga A, et al. Incidence and variables associated with inadequate antibody titers after pre-exposure rabies vaccination among veterinary medical students. Vaccine 2014;32:979-83.
14. Weisberg SS. Tetanus. Dis Mon 2007;53:519-21.
15. Oshinaike OO, Ojelabi OO, Ogbera AO, et al. Improving case fatality rate of adult tetanus in urban Nigeria: focus on better facilities of care. Trop Doct 2012;42:208-10.
16. Havers FP, Moro PL, Hunter P, et al. Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices -United States, 2019. MMWR Morb Mortal Wkly Rep 2020;69:77-83.
17. Plotkin SA. Vaccines: correlates of vaccine-induced immunity. Clin Infect Dis 2008;47:401-9.
18. Ovsyannikova IG, White SJ, Larrabee BR, et al. Leptin and leptin-related gene polymorphisms, obesity, and influenza A/H1N1vaccine-induced immune responses in older individuals. Vaccine 2014;32:881-7.
19. White SJ, Taylor MJ, Hurt RT, et al. Leptin-based adjuvants:an innovative approach to improve vaccine response. Vaccine 2013;31:1666-72.
20. Morgan OW, Bramley A, Fowlkes A, et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS One 2010;5:e9694.
21. Hernandez-Garduno E. Obesity is the comorbidity more strongly associated for Covid-19 in Mexico. A case-control study. Obes Res Clin Pract 2020;14:375- 79.
22. Kabir A, Pazouki A, Jafari M, et al. Comparing anti-hepatitis B antibody level in iranian obese or overweight with non-obese cases. Iran Biomed J 2017;21:197-202.
23. Yang S, Tian G, Cui Y, et al. Factors influencing immunologic response to hepatitis B vaccine in adults. Scientific reports 2016;6:27251.
24. Petras M, Olear V. Predictors of the immune response to booster immunisation against tetanus in Czech healthy adults. Epidemiol Infect 2018;146:2079-85.
25. Sheridan PA, Paich HA, Handy J, et al. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes 2012;36:1072-77.
26. Lim J, Song YJ, Park WS, et al. The immunogenicity of a single dose of hepatitis A virus vaccines (Havrix(R) and Epaxal (R)) in Korean young adults. Yonsei Med J 2014;55:126-31.
27. Gandhi M, Devaraj S, Haghpeykar HS, et al. The effect of body mass index on post-vaccination maternal and neonatal pertussis antibody levels. J Reprod Immunol 2015;112:34–7.
28. Reuman PD, Kubilis P, Hurni W, et al. The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults. Vaccine 1997;15(10):1157-61